Study wrapper · #40
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185.
Editor's note
This is a rebuttal review, not a primary study: the authors defend BPC-157 against a separate critical review (Jozwiak et al.) that raised concerns about tumour promotion, nitric-oxide-driven free-radical damage, and neurodegeneration. They argue that in animal models BPC-157 instead controls angiogenesis and the NO system and counters Parkinson's- and Alzheimer's-like changes, and they cite a favourable safety signal (no lethal dose reached in toxicology). Read this as scientific debate rather than settled fact. The claims on both sides rest almost entirely on rodent and in-vitro work; these are mechanistic signals, and human data are needed before any clinical conclusion. Notably, much of the supportive literature comes from one research group with disclosed commercial interests, so independent replication matters here. BPC-157 remains non-FDA-approved and was removed from the FDA Category-2 compounding list.
Plain-language abstract
This is a response article. Another group of scientists had published a review warning that BPC-157 might carry risks, for example encouraging tumour growth, producing harmful molecules, or worsening brain diseases. In this paper, the authors push back, arguing that in animal experiments BPC-157 appeared to do the opposite: helping to regulate blood-vessel growth, reducing harmful free radicals, and lessening Parkinson's- and Alzheimer's-like changes in mice and rats. They also point to toxicology studies in which no lethal dose was reached. It is important to understand that this is a scientific disagreement, and that the evidence being argued over comes from laboratory and animal studies, not human trials. No firm conclusions about benefit or harm in people can be drawn from this exchange.